Ownership

Kathleen Tregoning - Insider Trading & Ownership

Entity: Individual
Location: C/O Cerevel Therapeutics Holdings, Inc., 131 Dartmouth Street Suite 502, Boston, MA
Summary: The estimated net worth of Kathleen Tregoning is at least $120K dollars as of August 5, 2024. Kathleen Tregoning is the Director of Spero Therapeutics, Inc. and owns shares of Spero Therapeutics, Inc. (SPRO) stock worth about $120K.
All Insider Reports: All Insider Reports

Ownership of Kathleen Tregoning

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
SPRO	Spero Therapeutics, Inc.	Director	$120K			May 29, 2024
CERE	Cerevel Therapeutics Holdings, Inc.	Chief Corporate Affairs Officer	$0			Aug 1, 2024

Showing 1 to 2 of 2 entries

Insider Transactions Reported by Kathleen Tregoning:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.